Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

被引:217
|
作者
Abdul-Aziz, Mohd H. [1 ,2 ]
Sulaiman, Helmi [3 ]
Mat-Nor, Mohd-Basri [4 ]
Rai, Vineya [5 ]
Wong, Kang K. [5 ]
Hasan, Mohd S. [5 ]
Abd Rahman, Azrin N. [2 ,6 ]
Jamal, Janattul A. [7 ]
Wallis, Steven C. [1 ]
Lipman, Jeffrey [1 ,8 ]
Staatz, Christine E. [6 ,9 ]
Roberts, Jason A. [1 ,6 ,8 ]
机构
[1] Univ Queensland, Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Level 3,Ned Hanlon Bldg, Herston, Qld 4029, Australia
[2] Int Islamic Univ Malaysia, Sch Pharm, Kuantan, Pahang, Malaysia
[3] Univ Malaya, Dept Med, Infect Dis Unit, Fac Med, Kuala Lumpur, Malaysia
[4] Int Islamic Univ Malaysia, Sch Med, Dept Anaesthesiol & Intens Care, Kuantan, Pahang, Malaysia
[5] Univ Malaya, Dept Anaesthesiol, Fac Med, Kuala Lumpur, Malaysia
[6] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[7] Hosp Tengku Ampuan Afzan, Dept Pharm, Kuantan, Malaysia
[8] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[9] Australian Ctr Pharmacometr, Brisbane, Qld, Australia
关键词
Antibiotics; Critically ill; Intermittent bolus; Pharmacokinetics; Pharmacodynamics; Prolonged infusion; CARE-UNIT PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; DEFINING ANTIBIOTIC LEVELS; INTENSIVE-CARE; CEFTAZIDIME; PIPERACILLIN; MEROPENEM; CEFEPIME; EFFICACY; PHARMACOKINETICS;
D O I
10.1007/s00134-015-4188-0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study aims to determine if continuous infusion (CI) is associated with better clinical and pharmacokinetic/pharmacodynamic (PK/PD) outcomes compared to intermittent bolus (IB) dosing in critically ill patients with severe sepsis. This was a two-centre randomised controlled trial of CI versus IB dosing of beta-lactam antibiotics, which enrolled critically ill participants with severe sepsis who were not on renal replacement therapy (RRT). The primary outcome was clinical cure at 14 days after antibiotic cessation. Secondary outcomes were PK/PD target attainment, ICU-free days and ventilator-free days at day 28 post-randomisation, 14- and 30-day survival, and time to white cell count normalisation. A total of 140 participants were enrolled with 70 participants each allocated to CI and IB dosing. CI participants had higher clinical cure rates (56 versus 34 %, p = 0.011) and higher median ventilator-free days (22 versus 14 days, p < 0.043) than IB participants. PK/PD target attainment rates were higher in the CI arm at 100 % fT (> MIC) than the IB arm on day 1 (97 versus 70 %, p < 0.001) and day 3 (97 versus 68 %, p < 0.001) post-randomisation. There was no difference in 14-day or 30-day survival between the treatment arms. In critically ill patients with severe sepsis not receiving RRT, CI demonstrated higher clinical cure rates and had better PK/PD target attainment compared to IB dosing of beta-lactam antibiotics. Continuous beta-lactam infusion may be mostly advantageous for critically ill patients with high levels of illness severity and not receiving RRT. Malaysian National Medical Research Register ID: NMRR-12-1013-14017.
引用
收藏
页码:1535 / 1545
页数:11
相关论文
共 36 条
  • [1] Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
    Mohd H. Abdul-Aziz
    Helmi Sulaiman
    Mohd-Basri Mat-Nor
    Vineya Rai
    Kang K. Wong
    Mohd S. Hasan
    Azrin N. Abd Rahman
    Janattul A. Jamal
    Steven C. Wallis
    Jeffrey Lipman
    Christine E. Staatz
    Jason A. Roberts
    [J]. Intensive Care Medicine, 2016, 42 : 1535 - 1545
  • [2] A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study
    Dulhunty, Joel M.
    Roberts, Jason A.
    Davis, Joshua S.
    Webb, Steven A. R.
    Bellomo, Rinaldo
    Gomersall, Charles
    Shirwadkar, Charudatt
    Eastwood, Glenn M.
    Myburgh, John
    Paterson, David L.
    Starr, Therese
    Udy, Andrew A.
    Paul, Sanjoy K.
    Lipman, Jeffrey
    [J]. CRITICAL CARE AND RESUSCITATION, 2013, 15 (03) : 179 - 185
  • [3] Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations
    Barton, Greg
    Rickard, Claire M.
    Roberts, Jason A.
    [J]. INTENSIVE CARE MEDICINE, 2024,
  • [4] BLISS – Kontinuierliche Infusion von β‑Lactam-Antibiotika bei schwerer SepsisContinuous infusion of beta-lactam antibiotics in severe sepsis (BLISS)
    S. Hagel
    M. Pletz
    [J]. Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2016, 111 (8) : 729 - 730
  • [5] Beta-lactam antibiotics in continuous infusion in critically ill patients
    Axel Jeurissen
    Robert Rutsaert
    [J]. Critical Care, 14
  • [6] Beta-lactam antibiotics in continuous infusion in critically ill patients
    Jeurissen, Axel
    Rutsaert, Robert
    [J]. CRITICAL CARE, 2010, 14 (05):
  • [7] Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
    Dulhunty, Joel M.
    Roberts, Jason A.
    Davis, Joshua S.
    Webb, Steven A. R.
    Bellomo, Rinaldo
    Gomersall, Charles
    Shirwadkar, Charudatt
    Eastwood, Glenn M.
    Myburgh, John
    Paterson, David L.
    Lipman, Jeffrey
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (02) : 236 - 244
  • [8] Beta-lactam antibiotics in continuous infusion in critically ill patients response
    Taccone, Fabio Silvio
    Vincent, Jean-Louis
    Jacobs, Frederique
    [J]. CRITICAL CARE, 2010, 14 (05):
  • [9] Continuous beta-lactam infusion in critically ill patients: the clinical evidence
    Abdul-Aziz, Mohd H.
    Dulhunty, Joel M.
    Bellomo, Rinaldo
    Lipman, Jeffrey
    Roberts, Jason A.
    [J]. ANNALS OF INTENSIVE CARE, 2012, 2
  • [10] Continuous beta-lactam infusion in critically ill patients: the clinical evidence
    Mohd H Abdul-Aziz
    Joel M Dulhunty
    Rinaldo Bellomo
    Jeffrey Lipman
    Jason A Roberts
    [J]. Annals of Intensive Care, 2